Based on the established associations between changes in the co-expression of TNFRs and pathologic conditions, we hypothesized that the expression and co-expression patterns of TNFR1 and TNFR2 could serve as diagnostic tools to assess the disease severity and predict the response to therapy in patients with BA. This evidence concerns the gene TNFRSF1B and breast angiosarcoma.